Parkinson's Disease, Diabetes and Cognitive Impairment.
CONCLUSION: Further studies using GLP-1 agonists and DPP-4 inhibitors to treat PD are warranted as they have shown promise.
PMID: 27396477 [PubMed - as supplied by publisher]
Source: Recent Patents on Endocrine, Metabolic and Immune Drug Discovery - Category: Endocrinology Tags: Recent Pat Endocr Metab Immune Drug Discov Source Type: research
More News: Brain | Databases & Libraries | Diabetes | Endocrinology | Fortamet | Insulin | Metformin | Mitochondrial Disease | Neurology | Parkinson's Disease | Study